Biotech Values

[rstor1]

Thanks for the warning Dew.

It was an impulse buy - much less DD than appropriate. I looked at the dose-dependent results, I looked at the mode of admisistration, I looked at the tiny cap, and there did not seem to be a large downside vs the potential upside. It was worth a few thousand $.

Now I have to learn the company.

I've been doing this long enough that I should know the right way by now, but sometimes you go with your gut.

Regards,
Bob